<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">J Med Case Rep</journal-id>
      <journal-id journal-id-type="iso-abbrev">J Med Case Rep</journal-id>
      <journal-title-group>
        <journal-title>Journal of Medical Case Reports</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1752-1947</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27094915</article-id>
      <article-id pub-id-type="pmc">4837582</article-id>
      <article-id pub-id-type="publisher-id">882</article-id>
      <article-id pub-id-type="doi">10.1186/s13256-016-0882-y</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Cerebrotendinous xanthomatosis (a rare lipid storage disorder): a case report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Razi</surname>
            <given-names>Syed Mohd</given-names>
          </name>
          <address>
            <email>syedrazi1983@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Abhinav Kumar</given-names>
          </name>
          <address>
            <email>abhinavgupta2026@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Deepak Chand</given-names>
          </name>
          <address>
            <email>deepak_fortis@yahoo.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gutch</surname>
            <given-names>Manish</given-names>
          </name>
          <address>
            <email>manish07gutch@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Gupta</surname>
            <given-names>Keshav Kumar</given-names>
          </name>
          <address>
            <email>drkkgupta121292@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Usman</surname>
            <given-names>Syeda Iqra</given-names>
          </name>
          <address>
            <email>s.iqra.u@gmail.com</email>
          </address>
          <xref ref-type="aff" rid="Aff2"/>
        </contrib>
        <aff id="Aff1"><label/>Department of Endocrinology, Lala Lajpat Rai Memorial Medical College, Garh Raod, Meerut, 250004 Uttar Pradesh India </aff>
        <aff id="Aff2"><label/>Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, 202002 Uttar Pradesh India </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>19</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>19</day>
        <month>4</month>
        <year>2016</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2016</year>
      </pub-date>
      <volume>10</volume>
      <elocation-id>103</elocation-id>
      <history>
        <date date-type="received">
          <day>9</day>
          <month>12</month>
          <year>2015</year>
        </date>
        <date date-type="accepted">
          <day>22</day>
          <month>3</month>
          <year>2016</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Razi et al. 2016</copyright-statement>
        <license license-type="OpenAccess">
          <license-p>
<bold>Open Access</bold>This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>Cerebrotendinous xanthomatosis is a very rare autosomal recessive lipid storage disorder affecting bile acid biosynthesis. It is manifested by subtle neurological and non-neurological symptoms due to abnormal tissue lipid deposition. Diagnosis is usually delayed but early diagnosis and replacement therapy can prevent devastating neurological sequelae.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>We present a case of a 25-year-old Asian Indian woman who presented with gait difficulty, fusiform swellings of bilateral tendo-Achilles and infrapatellar tendons, along with history of bilateral cataract surgery 1&#xA0;year earlier. The diagnosis was made on the basis of clinical, biochemical, imaging, and histopathological analysis and replacement therapy was started.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>The peculiarity of the present case is the absence of any neurological manifestations which are usually the early clues to the diagnosis of cerebrotendinous xanthomatosis. The present case report emphasizes the fact that early age bilateral cataracts along with bilateral tendo-Achilles xanthomas can be early pointers toward the diagnosis of cerebrotendinous xanthomatosis.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Cerebrotendinous xanthomatosis</kwd>
        <kwd>
          <italic>CYP27A1</italic>
        </kwd>
        <kwd>Xanthoma</kwd>
        <kwd>Chenodeoxycholic acid</kwd>
        <kwd>Cholestanol</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2016</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Background</title>
      <p>Cerebrotendinous xanthomatosis (CTX) is a rare autosomal recessive lipid disorder: phenotype Online Mendelian Inheritance in Man (OMIM)#213700, gene OMIM#606530 [<xref ref-type="bibr" rid="CR1">1</xref>]. It is caused by mutations in gene <italic>CYP27A1</italic> located on the chromosome 2q33-qter causing lack of enzyme mitochondrial sterol 27-hydroxylase [<xref ref-type="bibr" rid="CR1">1</xref>]. <italic>CYP27A1</italic> plays a pivotal role in cholesterol side chain oxidation during the synthesis of chenodeoxycholic acid (CDCA) which is a bile acid [<xref ref-type="bibr" rid="CR2">2</xref>]. Therefore perturbations in <italic>CYP27A1</italic> gene result in reduced enzymatic activity causing impairment of cholesterol side chain oxidation finally culminating in excessive production and abnormal deposition of cholestanol in various tissues [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR2">2</xref>]. The classical triad of the syndrome consists of premature bilateral cataract, tendon xanthomas (predominantly involving tendo-Achilles) and various neurological abnormalities [<xref ref-type="bibr" rid="CR3">3</xref>]. A recent study by Appadurai <italic>et al</italic>. [<xref ref-type="bibr" rid="CR2">2</xref>] stated that in the absence of epidemiological studies the disease is considered to be exceedingly rare but it is actually underreported. This group studied the Exome Aggregation Consortium (ExAC) cohort of 60,000 unrelated adults globally for the frequency of 57 reported pathogenic variants of <italic>CYP27A1</italic> along with 29 additional variants through bioinformatics; they estimated that the incidence of CTX ranged from 1:134,970 to 1:461,358 in Europe, 1:263,222 to 1:468,624 in Africa, 1:71,677 to 1:148,914 in the USA, 1:64,267 to 1:64,712 in East Asia, and 1:36,072 to 1:468,624 in South Asia [<xref ref-type="bibr" rid="CR2">2</xref>]. However, another recent study by Ragno <italic>et al</italic>. stated that more than 300 cases have been reported so far with approximately 50 mutations with little correlation between genotype and phenotype [<xref ref-type="bibr" rid="CR4">4</xref>]. The mean age of onset of the symptoms is 19&#xA0;years while the mean age at diagnosis is 35&#xA0;years representing a lag of 16&#xA0;years in the diagnosis [<xref ref-type="bibr" rid="CR5">5</xref>]. A recent study of 19 patients from 15 unrelated Italian families by Mignarri <italic>et al</italic>. estimated the median age at diagnosis to be 32&#xA0;years while the mean age was 32.5&#xB1;10.4&#xA0;years [<xref ref-type="bibr" rid="CR6">6</xref>]. Replacement therapy with CDCA delays or even reverses the progression of the disease [<xref ref-type="bibr" rid="CR3">3</xref>]; however, because there is a lag period between the onset of symptoms and the mean age of diagnosis [<xref ref-type="bibr" rid="CR1">1</xref>], early diagnosis is required to prevent devastating neurological sequelae and other complications such as premature atherosclerosis and osteoporosis. So a high index of suspicion should be kept in any patient encountered with the classical triad as illustrated in the present case report.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 25-year-old Asian Indian woman presented with complaints of swellings behind both her ankles and in front of both her knees for the last 2&#xA0;years. These swellings had an insidious onset; they were painless, gradually progressive, and caused difficulty in walking for the last 1&#xA0;year. She had history of bilateral cataract surgery 1&#xA0;year earlier. There was no history of childhood diarrhea, seizures, cerebellar symptoms, psychiatric manifestations, mental retardation, or premature atherosclerosis. There was no family history of similar complaints.</p>
      <p>On examination, she had firm, non-tender, fusiform swellings over bilateral tendo-Achilles (right 10&#xD7;4.5&#xA0;cm, left 8&#xD7;3&#xA0;cm) and bilateral infrapatellar tendons (right 2&#xD7;1.5&#xA0;cm, left 1.5&#xD7;1.2&#xA0;cm) as shown in Fig.&#xA0;<xref rid="Fig1" ref-type="fig">1a, b</xref>. Her general examination was unremarkable except for bilateral pseudophakic eyes. On neurological examination, her higher mental functions were normal. Her pupils were normal sized and normally reactive. Her sensory system was unremarkable. Her muscle bulk, tone, power, coordination, and other motor system functions were normal. All her cranial nerves were normal. Her cardiac, abdominal and respiratory examinations were also unremarkable.<fig id="Fig1"><label>Fig. 1</label><caption><p>
<bold>a</bold> Bilateral fusiform tendo-Achilles xanthomas: right 10&#xD7;4.5&#xA0;cm, left 8&#xD7;3&#xA0;cm. <bold>b</bold> Bilateral infrapatellar tendon xanthomas: right 2&#xD7;1.5&#xA0;cm, left 1.5&#xD7;1.2&#xA0;cm</p></caption><graphic xlink:href="13256_2016_882_Fig1_HTML" id="MO1"/></fig></p>
      <p>Her hemogram, renal function test, hepatic function test, serum electrolytes, and fasting lipid profile were within the normal limits. Her serum cholestanol level was 4.27&#xA0;mg/dl (normal value 0.02 to 0.12&#xA0;mg/dl). Serum and urinary bile alcohol could not be done because of unavailability. Electrocardiography, two-dimensional echocardiography, spirometry, and nerve conduction study were unremarkable. X-rays of both her legs revealed soft tissue thickening in bilateral ankles posteriorly and overlying right tibial tuberosity as shown in Fig.&#xA0;<xref rid="Fig2" ref-type="fig">2</xref>. Ultrasonography of bilateral tendo-Achilles revealed anteroposterior thickness of 7.5&#xA0;mm and loss of normal tendon appearance with multiple hypoechoic foci within the tendon as shown in Fig.&#xA0;<xref rid="Fig3" ref-type="fig">3</xref>. Magnetic resonance imaging (MRI) of her brain revealed T2 and fluid-attenuated inversion recovery (FLAIR) hyperintense signals in the region of the dentate nucleus of both her cerebellar hemispheres with high choline and low N-acetylaspartate (NAA)/creatine peaks on magnetic resonance spectroscopy (MRS) as shown in Fig.&#xA0;<xref rid="Fig4" ref-type="fig">4a, b</xref>. She underwent excisional biopsy of her right infrapatellar which yielded a gray, brown, soft tissue measuring 2&#xD7;2&#xD7;1&#xA0;cm on gross examination as shown in Fig.&#xA0;<xref rid="Fig5" ref-type="fig">5a</xref>. Microscopic examination revealed foamy cells admixed with inflammatory cells and giant cells surrounding cholesterol clefts as shown in Fig. <xref rid="Fig5" ref-type="fig">5b</xref>. On the basis of these findings the diagnosis of CTX was made and she was started on replacement with CDCA 250&#xA0;mg three times a day, ursodeoxycholic acid 300&#xA0;mg three times a day, and atorvastatin 10&#xA0;mg at bedtime.<fig id="Fig2"><label>Fig. 2</label><caption><p>X-ray showing soft tissue thickening of bilateral tendo-Achilles</p></caption><graphic xlink:href="13256_2016_882_Fig2_HTML" id="MO2"/></fig><fig id="Fig3"><label>Fig. 3</label><caption><p>Ultrasonography of tendo-Achilles showing anteroposterior thickness of 7.5&#xA0;mm with loss of normal tendon appearance and multiple hypoechoic foci within tendon</p></caption><graphic xlink:href="13256_2016_882_Fig3_HTML" id="MO3"/></fig><fig id="Fig4"><label>Fig. 4</label><caption><p>
<bold>a</bold> Brain magnetic resonance imaging T2 sequence showing hyperintensities in bilateral dentate nuclei. <bold>b</bold> Magnetic resonance spectroscopy showing high choline and low N-acetylaspartate/creatine peaks</p></caption><graphic xlink:href="13256_2016_882_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Fig. 5</label><caption><p>
<bold>a</bold> Gross &#x2013; excisional biopsy specimen from right infrapatellar tendon xanthomas measuring 2&#xD7;2&#xD7;1&#xA0;cm with gray, brown, soft tissue. <bold>b</bold> Microscopic analysis &#x2013; showing foamy cells admixed with inflammatory cells and giant cells surrounding cholesterol clefts</p></caption><graphic xlink:href="13256_2016_882_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec3" sec-type="discussion">
      <title>Discussion</title>
      <p>CTX is a rare autosomal recessive inborn error of bile acid synthesis first reported by Von Bogaert in 1937. The disease is caused by mutation in gene <italic>CYP27A1</italic> located on chromosome 2q33-qter leading to a lack of mitochondrial sterol 27-hydroxylase enzyme at the inner mitochondrial membrane in almost all cells of the body [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR8">8</xref>]. Absence of sterol 27-hydroxylase enzyme activity causes deficiency of CDCA and cholic acid leading to a loss of feedback inhibition of rate-limiting enzyme cholesterol 7&#x3B1;-hydroxylase (CYP7A1) of bile synthesis, which results in excess production of cholestanol which gets deposited in various tissues [<xref ref-type="bibr" rid="CR1">1</xref>&#x2013;<xref ref-type="bibr" rid="CR3">3</xref>].</p>
      <p>The diagnosis is delayed due to subtle manifestations and the rarity of the disease [<xref ref-type="bibr" rid="CR1">1</xref>]. The disease has multiorgan involvement such as bilateral premature cataracts, intractable childhood diarrhea, tendon xanthomas, neurological abnormalities, and premature atherosclerosis. The usual manifestations are due to deposition of excess cholestanol and cholesterol in the affected tissues [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>]. Our patient presented with bilateral tendo-Achilles tuberous xanthomas along with premature bilateral cataracts but no neurological abnormalities.</p>
      <p>Familial hypercholesterolemia and sitosterolemia are the two important differential diagnoses of CTX. CTX is differentiated clinically from other disorders of lipid metabolism because of juvenile cataracts, progressive neurological symptoms, mild pulmonary insufficiency, and increased levels of cholestanol [<xref ref-type="bibr" rid="CR9">9</xref>]. In the absence of tendinous xanthomas, CTX may be confused with Marinesco&#x2013;Sj&#xF6;gren syndrome as it also presents with early age cataracts, cerebellar ataxia, neuromuscular weakness, and mental retardation but it can be differentiated from CTX by short stature, skeletal anomalies and hypergonadotropic hypogonadism [<xref ref-type="bibr" rid="CR10">10</xref>, <xref ref-type="bibr" rid="CR11">11</xref>].</p>
      <p>The laboratory findings include a normal or reduced serum cholesterol level, increased serum cholestanol, increased 7&#x3B1;-hydroxy-4-cholesten-3-one (7&#x3B1;C4), increased lathosterol, increased plant sterols (campesterol, sitosterol), increased serum and urinary bile acid alcohols but reduced serum CDCA and 27-hydroxycholesterol (27-OHC) [<xref ref-type="bibr" rid="CR6">6</xref>]. Typical MRI findings are bilateral T2 and FLAIR hyperintense, nonhomogeneous signals in dentate nuclei and surrounding cerebellum. There are diffuse or focal white matter abnormalities along with cerebral and cerebellar atrophy [<xref ref-type="bibr" rid="CR1">1</xref>, <xref ref-type="bibr" rid="CR3">3</xref>, <xref ref-type="bibr" rid="CR10">10</xref>]. MRS studies reveal increased lactate and lipid peaks in FLAIR sequence-hypointense lesions, and diffusely decreased NAA peaks. Microscopy reveals foamy cells admixed with inflammatory cells and giant cells surrounding cholesterol clefts [<xref ref-type="bibr" rid="CR1">1</xref>]. These laboratory findings exactly correlate with those of our patient in the present discussion.</p>
      <p>The treatment consists of replacement therapy, surgery and other symptomatic therapies. The replacement therapy can prevent or even reverse neurological complications and involves administration of bile acids such as CDCA, ursodeoxycholic acid, cholic acid, and taurocholic acid. Among these, CDCA is considered the drug of choice. Hydroxymethylglutaryl-CoA (HMG-CoA) synthase inhibitors are considered to enhance the effect of replacement therapy. Surgery may deteriorate gait imbalance and does not prevent neurological complications [<xref ref-type="bibr" rid="CR1">1</xref>].</p>
    </sec>
    <sec id="Sec4" sec-type="conclusion">
      <title>Conclusions</title>
      <p>CTX is a rare and underreported lipid storage disorder. Although it is medically manageable, a delay in diagnosis can be devastating for the patient so early diagnosis based on a high index of suspicion is imperative for better management.</p>
    </sec>
    <sec id="Sec5">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>The authors declare that they have no competing interests.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>All authors contributed to the treatment of the patient and to the conception, writing, and revision of the manuscript. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <p>The authors thank the team of Department of Endocrinology L.L.R.M. Medical College, Meerut for providing support and helping in the preparation of the manuscript.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nie</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Chen</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Cao</surname>
              <given-names>X</given-names>
            </name>
            <name>
              <surname>Zhang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management</article-title>
          <source>Orphanet J Rare Dis</source>
          <year>2014</year>
          <volume>9</volume>
          <issue>1</issue>
          <fpage>179</fpage>
          <pub-id pub-id-type="doi">10.1186/s13023-014-0179-4</pub-id>
          <pub-id pub-id-type="pmid">25424010</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Appadurai</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>DeBarber</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Chiang</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Steiner</surname>
              <given-names>RD</given-names>
            </name>
            <name>
              <surname>Tyler</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Apparent underdiagnosis of cerebrotendinous xanthomatosis revealed by analysis of ~60,000 human exomes</article-title>
          <source>Mol Genet Metab</source>
          <year>2015</year>
          <volume>116</volume>
          <issue>4</issue>
          <fpage>298</fpage>
          <lpage>304</lpage>
          <pub-id pub-id-type="doi">10.1016/j.ymgme.2015.10.010</pub-id>
          <pub-id pub-id-type="pmid">26643207</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sandeep</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Jayakrishnan</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sadanan</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sreekumar</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Thulasidharan</surname>
              <given-names>NK</given-names>
            </name>
          </person-group>
          <article-title>Cerebrotendinous xanthomatosis: a treatable neurodegenerative disease</article-title>
          <source>J Assoc Physicians India.</source>
          <year>2009</year>
          <volume>57</volume>
          <fpage>716</fpage>
          <lpage>7</lpage>
          <pub-id pub-id-type="pmid">20329433</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ragno</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Di Marzio</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Fuccio</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Pianese</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Cozzolino</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Carboni</surname>
              <given-names>T</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cerebellar hypometabolism with normal structural findings in cerebrotendinous xanthomatosis. A case report</article-title>
          <source>Clin Neurol Neurosurg</source>
          <year>2015</year>
          <volume>139</volume>
          <fpage>221</fpage>
          <lpage>3</lpage>
          <pub-id pub-id-type="doi">10.1016/j.clineuro.2015.10.020</pub-id>
          <pub-id pub-id-type="pmid">26519892</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pilo-de-la-Fuente</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Jimenez-Escrig</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Lorenzo</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Pardo</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Arias</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ares-Luque</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cerebrotendinous xanthomatosis in Spain: clinical, prognostic, and genetic survey</article-title>
          <source>Eur J Neurol</source>
          <year>2011</year>
          <volume>18</volume>
          <issue>10</issue>
          <fpage>1203</fpage>
          <lpage>11</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1468-1331.2011.03439.x</pub-id>
          <pub-id pub-id-type="pmid">21645175</pub-id>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mignarri</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Magni</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Del Puppo</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Gallus</surname>
              <given-names>GN</given-names>
            </name>
            <name>
              <surname>Bj&#xF6;rkhem</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>Federico</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Evaluation of cholesterol metabolism in cerebrotendinous xanthomatosis</article-title>
          <source>J Inherit Metab Dis.</source>
          <year>2015</year>
          <volume>8</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lorbek</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Lewinska</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Rozman</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Cytochrome P450s in the synthesis of cholesterol and bile acids &#x2013; from mouse models to human diseases</article-title>
          <source>FEBS J</source>
          <year>2012</year>
          <volume>279</volume>
          <issue>9</issue>
          <fpage>1516</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="doi">10.1111/j.1742-4658.2011.08432.x</pub-id>
          <pub-id pub-id-type="pmid">22111624</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Russell</surname>
              <given-names>DW</given-names>
            </name>
          </person-group>
          <article-title>The enzymes, regulation, and genetics of bile acid synthesis</article-title>
          <source>Annu Rev Biochem</source>
          <year>2003</year>
          <volume>72</volume>
          <issue>1</issue>
          <fpage>137</fpage>
          <lpage>74</lpage>
          <pub-id pub-id-type="doi">10.1146/annurev.biochem.72.121801.161712</pub-id>
          <pub-id pub-id-type="pmid">12543708</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chal&#xE8;s</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Coiffier</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Guggenbuhl</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Rare thesaurismosis and xanthomatosis</article-title>
          <source>Best Pract Res Clin Rheumatol</source>
          <year>2011</year>
          <volume>25</volume>
          <issue>5</issue>
          <fpage>683</fpage>
          <lpage>701</lpage>
          <pub-id pub-id-type="doi">10.1016/j.berh.2011.10.016</pub-id>
          <pub-id pub-id-type="pmid">22142747</pub-id>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jha</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Khateeb</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Sonker</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Cerebrotendinous xanthomatosis, early diagnosis mandatory: Report of a case from North India</article-title>
          <source>Neurol Asia</source>
          <year>2008</year>
          <volume>13</volume>
          <fpage>125</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Slavotinek</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Goldman</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Weisiger</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Kostiner</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Golabi</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Packman</surname>
              <given-names>S</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Marinesco&#x2013;Sj&#xF6;gren syndrome in a male with mild dysmorphism</article-title>
          <source>Am J Med Genet A</source>
          <year>2005</year>
          <volume>133</volume>
          <issue>2</issue>
          <fpage>197</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="doi">10.1002/ajmg.a.30504</pub-id>
          <pub-id pub-id-type="pmid">15633176</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
